Express Healthcare
Home  »  COVID-19 Updates  »  Ministry of Ayush issues statement on claims of Patanjali Ayurved regarding the treatment of COVID-19

Ministry of Ayush issues statement on claims of Patanjali Ayurved regarding the treatment of COVID-19

0 114
Read Article

Patanjali Ayurved has been asked to provide at the earliest details of the name and composition of the medicines being claimed for COVID treatment

Ministry of AYUSH has taken cognizance of the news being recently flashed in the media about Ayurvedic medicines developed for the treatment of COVID-19 by Patanjali Ayurved, Haridwar (Uttrakhand). Facts of the claim and details of the stated scientific study are not known to the Ministry.

The concerned Ayurvedic drug manufacturing company has been informed that such advertisements of drugs including Ayurvedic medicines are regulated under the provisions of Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and Rules thereunder and the directives issued by the Central Government in the wake of COVID outbreak. The ministry had also issued a Gazette Notification No. L.11011/8/2020/AS dated 21st April 2020 stating the requirements and the manner the research studies on COVID-19 with Ayush interventions/medicines should be undertaken.

In order to make this ministry aware of the facts of the aforesaid news and verify the claims,  Patanjali Ayurved has been asked to provide at the earliest details of the name and composition of the medicines being claimed for COVID treatment; site(s)/hospital(s), where the research study was conducted for COVID-19; protocol, sample size, Institutional Ethics Committee clearance, CTRI registration and results from data of the study (ies) and stop advertising/publicizing such claims till the issue is duly examined.

The ministry has also requested the concerned state licensing authority of Uttarakhand Government to provide copies of license and product approval details of the Ayurvedic medicines being claimed for the treatment of COVID-19.

Leave A Reply

Your email address will not be published.

Attend an exclusive webinar to know more about biomarkers in diagnosis & therapy management of heart failure.
Register Now
close-image
 Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Know More?
close-image
Are you looking for ICP-MS which can increase productivity and remove time trap from your analysis?
Know More
close-image